(PUM) PUMA SE - Overview
Sector: Consumer Cyclical | Industry: Footwear & Accessories | Exchange: XETRA (Germany) | Market Cap: 3.177m EUR | Total Return: 11.6% in 12m
Stock
Apparel, Footwear, Accessories, Licensing
Total Rating 35
Safety 72
Buy Signal -0.38
Market Cap:
3,682m
Avg Trading Vol: 15.5M EUR
Avg Trading Vol: 15.5M EUR
ATR:
5.25%
Peers RS (IBD): 85.0
Peers RS (IBD): 85.0
Risk 5d forecast
Volatility55.4%
Rel. Tail Risk-22.7%
Reward TTM
Sharpe Ratio0.20
Alpha-25.57
Character TTM
Beta1.330
Beta Downside1.876
Drawdowns 3y
Max DD75.18%
CAGR/Max DD-0.34
EPS (Earnings per Share)
EPS CAGR: -6.49%
EPS Trend: -66.2%
EPS Trend: -66.2%
Last SUE: 0.71
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: -5.20%
Rev. Trend: -37.6%
Rev. Trend: -37.6%
Last SUE: 0.78
Qual. Beats: 0
Qual. Beats: 0
Risks
Technicals:
choppy
Description: PUM PUMA SE
PUMA SE designs and sells sports and sports lifestyle products globally. The company operates in the athletic apparel and footwear sector, a market characterized by strong brand loyalty and product innovation. PUMAs product range includes gear for various sports such as football, basketball, and motorsports.
The business model combines direct sales through retail stores and e-commerce with wholesale distribution. Additionally, PUMA licenses its brands for products like eyewear and workwear, a common practice in the consumer goods industry to expand brand reach without direct manufacturing. PUMA SE was founded in 1919 and is headquartered in Germany.
Further analysis of PUMAs financial performance can be found on ValueRay.
- Footwear and apparel sales drive majority revenue
- Supply chain disruptions impact production costs
- Marketing spend influences brand perception and sales
- Consumer discretionary spending affects product demand
- Licensing agreements provide royalty income
Piotroski VR‑10 (Strict)
2.5
| Net Income: -643.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.10 > 0.02 and ΔFCF/TA -15.84 > 1.0 |
| NWC/Revenue: 7.61% < 20% (prev 16.27%; Δ -8.66% < -1%) |
| CFO/TA -0.08 > 3% & CFO -524.9m > Net Income -643.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (147.6m) vs 12m ago -0.07% < -2% |
| Gross Margin: 45.53% > 18% (prev 0.51%; Δ 4.50k% > 0.5%) |
| Asset Turnover: 110.9% > 50% (prev 123.5%; Δ -12.58% > 0%) |
| Interest Coverage Ratio: 0.11 > 6 (EBITDA TTM -233.7m / Interest Expense TTM 174.7m) |
Altman Z''
1.98
| A: 0.09 (Total Current Assets 3.77b - Total Current Liabilities 3.20b) / Total Assets 6.45b |
| B: 0.31 (Retained Earnings 1.99b / Total Assets 6.45b) |
| C: 0.00 (EBIT TTM 19.8m / Avg Total Assets 6.80b) |
| D: 0.36 (Book Value of Equity 1.68b / Total Liabilities 4.69b) |
| Altman-Z'' Score: 1.98 = BBB |
Beneish M
-2.93
| DSRI: 1.13 (Receivables 1.22b/1.27b, Revenue 7.54b/8.82b) |
| GMI: 1.12 (GM 45.53% / 51.12%) |
| AQI: 1.01 (AQ_t 0.13 / AQ_t-1 0.13) |
| SGI: 0.86 (Revenue 7.54b / 8.82b) |
| TATA: -0.02 (NI -643.8m - CFO -524.9m) / TA 6.45b) |
| Beneish M-Score: -2.93 (Cap -4..+1) = A |
What is the price of PUM shares?
As of April 05, 2026, the stock is trading at EUR 21.71 with a total of 607,688 shares traded.
Over the past week, the price has changed by +2.70%, over one month by +1.01%, over three months by -1.78% and over the past year by +11.59%.
Over the past week, the price has changed by +2.70%, over one month by +1.01%, over three months by -1.78% and over the past year by +11.59%.
Is PUM a buy, sell or hold?
PUMA SE has no consensus analysts rating.
What are the forecasts/targets for the PUM price?
| Wallstreet Target Price | 26.6 | 22.3% |
| Analysts Target Price | - | - |
PUM Fundamental Data Overview
as of 05 April 2026
Market Cap USD = 3.68b (3.18b EUR * 1.159 EUR.USD)P/E Forward = 49.0196
P/S = 0.4354
P/B = 1.677
P/EG = 0.9929
Revenue TTM = 7.54b EUR
EBIT TTM = 19.8m EUR
EBITDA TTM = -233.7m EUR
Long Term Debt = 424.2m EUR (from longTermDebt, last quarter)
Short Term Debt = 1.15b EUR (from shortTermDebt, last quarter)
Debt = 2.58b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.29b EUR (from netDebt column, last quarter)
Enterprise Value = 5.47b EUR (3.18b + Debt 2.58b - CCE 290.0m)
Interest Coverage Ratio = 0.11 (Ebit TTM 19.8m / Interest Expense TTM 174.7m)
EV/FCF = -8.65x (Enterprise Value 5.47b / FCF TTM -632.3m)
FCF Yield = -11.56% (FCF TTM -632.3m / Enterprise Value 5.47b)
FCF Margin = -8.39% (FCF TTM -632.3m / Revenue TTM 7.54b)
Net Margin = -8.54% (Net Income TTM -643.8m / Revenue TTM 7.54b)
Gross Margin = 45.53% ((Revenue TTM 7.54b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Gross Margin QoQ = 43.29% (prev 45.25%)
Tobins Q-Ratio = 0.85 (Enterprise Value 5.47b / Total Assets 6.45b)
Interest Expense / Debt = 1.64% (Interest Expense 42.3m / Debt 2.58b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 14.9m (EBIT 19.8m * (1 - 25.00%))
Current Ratio = 1.18 (Total Current Assets 3.77b / Total Current Liabilities 3.20b)
Debt / Equity = 1.47 (Debt 2.58b / totalStockholderEquity, last quarter 1.76b)
Debt / EBITDA = -9.81 (negative EBITDA) (Net Debt 2.29b / EBITDA -233.7m)
Debt / FCF = -3.63 (negative FCF - burning cash) (Net Debt 2.29b / FCF TTM -632.3m)
Total Stockholder Equity = 2.14b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.47% (Net Income -643.8m / Total Assets 6.45b)
RoE = -30.05% (Net Income TTM -643.8m / Total Stockholder Equity 2.14b)
RoCE = 0.77% (EBIT 19.8m / Capital Employed (Equity 2.14b + L.T.Debt 424.2m))
RoIC = 0.57% (NOPAT 14.9m / Invested Capital 2.61b)
WACC = 6.43% (E(3.18b)/V(5.76b) * Re(10.66%) + D(2.58b)/V(5.76b) * Rd(1.64%) * (1-Tc(0.25)))
Discount Rate = 10.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.57%
[DCF] Fair Price = unknown (Cash Flow -632.3m)
EPS Correlation: -66.17 | EPS CAGR: -6.49% | SUE: 0.71 | # QB: 0
Revenue Correlation: -37.58 | Revenue CAGR: -5.20% | SUE: 0.78 | # QB: 0
EPS next Quarter (2026-06-30): EPS=-0.48 | Chg7d=+0.210 | Chg30d=-0.481 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-12-31): EPS=-1.56 | Chg7d=+0.015 | Chg30d=-0.224 | Revisions Net=-7 | Growth EPS=+52.3% | Growth Revenue=-5.1%
EPS next Year (2027-12-31): EPS=0.41 | Chg7d=+0.007 | Chg30d=-0.006 | Revisions Net=-4 | Growth EPS=+126.2% | Growth Revenue=+6.9%
[Analyst] Revisions Ratio: -0.78 (1 Up / 8 Down within 30d for Current Year)